These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 7926302)

  • 1. Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group.
    Petersen JS; Dyrberg T; Karlsen AE; Mølvig J; Michelsen B; Nerup J; Mandrup-Poulsen T
    Diabetes; 1994 Nov; 43(11):1291-6. PubMed ID: 7926302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
    Mandrup-Poulsen T; Mølvig J; Andersen HU; Helqvist S; Spinas GA; Munck M
    Diabetes; 1990 Feb; 39(2):204-10. PubMed ID: 2227128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.
    Gorus FK; Goubert P; Semakula C; Vandewalle CL; De Schepper J; Scheen A; Christie MR; Pipeleers DG
    Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay.
    Petersen JS; Hejnaes KR; Moody A; Karlsen AE; Marshall MO; Høier-Madsen M; Boel E; Michelsen BK; Dyrberg T
    Diabetes; 1994 Mar; 43(3):459-67. PubMed ID: 8314020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.
    Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
    Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W
    J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
    Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
    J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test.
    Wiest-Ladenburger U; Hartmann R; Hartmann U; Berling K; Böhm BO; Richter W
    Diabetes; 1997 Apr; 46(4):565-71. PubMed ID: 9075795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet cell antibodies, but not glutamic acid decarboxylase antibodies, are decreased by plasmapheresis in patients with newly diagnosed insulin-dependent diabetes mellitus.
    Sundkvist G; Hagopian WA; Landin-Olsson M; Lernmark A; Ohlsson L; Ericsson C; Ahlmén J
    J Clin Endocrinol Metab; 1994 May; 78(5):1159-65. PubMed ID: 8175973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of autoantibodies to glutamic acid decarboxylase in long-standing IDDM is not a marker of symptomatic autonomic neuropathy.
    Zanone MM; Petersen JS; Peakman M; Mathias CJ; Watkins PJ; Dyrberg T; Vergani D
    Diabetes; 1994 Sep; 43(9):1146-51. PubMed ID: 8070615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM.
    Grubin CE; Daniels T; Toivola B; Landin-Olsson M; Hagopian WA; Li L; Karlsen AE; Boel E; Michelsen B; Lernmark A
    Diabetologia; 1994 Apr; 37(4):344-50. PubMed ID: 8063033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM.
    Falorni A; Ackefors M; Carlberg C; Daniels T; Persson B; Robertson J; Lernmark A
    Diabetologia; 1996 Sep; 39(9):1091-8. PubMed ID: 8877294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GAD65 autoantibodies in women with gestational or insulin dependent diabetes mellitus diagnosed during pregnancy.
    Petersen JS; Dyrberg T; Damm P; Kühl C; Mølsted-Pedersen L; Buschard K
    Diabetologia; 1996 Nov; 39(11):1329-33. PubMed ID: 8933000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
    Myers MA; Rabin DU; Rowley MJ
    Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
    Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-GAD65 autoantibody in Taiwanese patients with insulin-dependent diabetes mellitus: effect of HLA on anti-GAD65 positivity and clinical characteristics.
    Chuang LM; Lin CY; Wu HP; Tsai WY; Tai TY; Lin BJ
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):455-61. PubMed ID: 9404444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.
    Bonifacio E; Genovese S; Braghi S; Bazzigaluppi E; Lampasona V; Bingley PJ; Rogge L; Pastore MR; Bognetti E; Bottazzo GF
    Diabetologia; 1995 Jul; 38(7):816-22. PubMed ID: 7556984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus.
    Walikonis JE; Lennon VA
    Mayo Clin Proc; 1998 Dec; 73(12):1161-6. PubMed ID: 9868413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes.
    Ujihara N; Daw K; Gianani R; Boel E; Yu L; Powers AC
    Diabetes; 1994 Aug; 43(8):968-75. PubMed ID: 8039604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity of islet cell antibodies (ICA) to recombinant glutamic acid decarboxylase (GAD).
    Guazzarotti L; Thivolet C; Tardivel I; Chevalier A; Carel JC
    J Autoimmun; 1995 Dec; 8(6):901-14. PubMed ID: 8824714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.